December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

329.89 -10.27 (-3.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
61 62 Next >
News headline image
Activision Stock Jumps As U.S. Judge Clears Hurdle To Microsoft Buyout ↗
Activision stock rocketed after a court allowed Microsoft to proceed with its $69 billion acquisition of the video game publisher. 
Via Investor's Business Daily
News headline image
Viridian Wants To Take On Horizon; Why This Update In Thyroid Eye Disease Fell Flat ↗
Shares tumbled after the biotech company unveiled the results of its chronic TED treatment. 
Via Investor's Business Daily
News headline image
What Does Amgen's Debt Look Like? ↗
 
Via Benzinga
News headline image
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today ↗
 
Via Benzinga
News headline image
2 Struggling Dividend Growth Stocks That Could Make You Richer ↗
Let's look beyond these drugmakers' ongoing issues. 
Via The Motley Fool
News headline image
Amgen: Are Its Golden Days Over? ↗
AMGN has grown revenues by a CAGR of 4.73%, net income by 5.38%, and dividends by an impressive 21.11%. 
Via Talk Markets
News headline image
How Is The Market Feeling About Amgen? ↗
 
Via Benzinga
News headline image
7 Analysts Have This to Say About Amgen ↗
 
Via Benzinga
News headline image
A Look Into Amgen Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today ↗
 
Via Benzinga
News headline image
Treasury Yields Spiking As Market Looks Ahead To Jobs Data, Raising Valuation Concerns ↗
(Thursday market open) Things are heating up, and we’re not just talking about the July weather. A week from the start of Q2 earnings season, Wall Street is on tenterhooks awaiting tomorrow’s crucial... 
Via Benzinga
News headline image
3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025 ↗
In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025 
Via InvestorPlace
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023 ↗
The stock market rebounded in 2023 with top indexes trading higher after 2022, which saw market declines. 
Via Benzinga
News headline image
Amgen's Debt Overview ↗
 
Via Benzinga
News headline image
Amgen Inc. Dividend Stock Analysis ↗
The company has paid a cash dividend to shareholders every year since 2011 and has increased its dividend payments for 13 consecutive years. 
Via Talk Markets
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck ↗
 
Via Benzinga
News headline image
What Will Amgen Buy Next? ↗
The biotech could pursue these two budget-friendly targets. 
Via The Motley Fool
News headline image
5 High-Yielding Dividend Stocks That Are Bargain Buys ↗
This is a good time for investors to load up on healthcare companies. 
Via The Motley Fool
News headline image
5 Top Dividend Stocks to Buy in July 2023 ↗
All 5 of these dividends stocks appear undervalued. 
Via The Motley Fool
News headline image
Activision Blizzard Shares up 1.83% Amid Regulators' Blunders
Shares of Microsoft Corp. (NASDAQ: MSFT) declined 1.92% on June 26, more than the broader market, while Activision Blizzard Inc. (NASDAQ: ATVI) rose 1.83%. The S&P 500 declined 0.41% in the session. 
Via MarketBeat
Topics Stocks
News headline image
Next-Gen Weight-Loss Drugs Set To Up The Game From Ozempic And Mounjaro: WSJ ↗
 
Via Benzinga
News headline image
Why Viking Therapeutics Stock Is Crashing Today ↗
Investors seem concerned about the company's competitive positioning in weight loss. 
Via The Motley Fool
News headline image
Why Amgen Stock Slumped on Monday ↗
Already under fire on the regulatory front, the company is hit with a price-target cut. 
Via The Motley Fool
News headline image
Russian Insurrection Crushed: 5 Stocks That Continue To Have Exposure To The Country ↗
 
Via Benzinga
News headline image
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire ↗
Buy 'em and then just get out of the way. Time and these companies' long-term strength will take care of the rest. 
Via The Motley Fool
News headline image
Moderating Inflation, a Tasty IPO, Bull Market Talk, and More ↗
We've also got two stocks worth watching: Chevron and Burford Capital. 
Via The Motley Fool
News headline image
Alleged Industrial Espionage Makes an Interesting Story ↗
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment. 
Via The Motley Fool
News headline image
How to Retire Rich: Biotech Stocks Edition ↗
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks. 
Via InvestorPlace
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.